𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cerebrovascular reserve capacity in patients with hyperlipidemia

✍ Scribed by Kerenyi, Levente L.; Fulesdi, Bela; Ficzere, Andrea; Kaposzta, Zoltan; Valikovics, Attila; Paragh, Gyorgy; Csiba, Laszlo


Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
175 KB
Volume
28
Category
Article
ISSN
0091-2751

No coin nor oath required. For personal study only.

✦ Synopsis


Purpose. Because recent data are conflicting, it is not certain whether hyperlipidemia is an independent risk factor for cerebrovascular diseases. Decreased cerebrovascular reserve capacity refers to the decreased ability of the cerebral arterioles to adapt in critical conditions and probably predicts a higher risk of stroke. The aim of this study was to compare cerebrovascular reserve capacity in hyperlipidemic patients and healthy controls using transcranial Doppler sonography.

Methods. Thirty-four hyperlipidemic patients and 21 healthy controls were examined. With transcranial Doppler sonography, the mean blood flow velocity in the middle cerebral artery was registered at rest and at 5, 10, 15, and 20 minutes after intravenous administration of 1,000 mg acetazolamide. Cerebrovascular reactivity and reserve capacity were calculated from mean blood flow velocities. Various laboratory measurements were also made and assessed for correlation with resting cerebral blood flow velocity and cerebrovascular reserve capacity.

Results. No significant differences could be observed between controls and hyperlipidemic patients in cerebrovascular reactivity or cerebrovascular reserve capacity. No correlation was found between various laboratory measurements and resting cerebral blood flow velocity or cerebrovascular reserve capacity.

Conclusions. We could not demonstrate any differences in cerebrovascular reserve capacity between hyperlipidemic patients and healthy controls. Thus, the vasodilatory ability of the cerebral arterioles seems to remain unchanged in this patient group and is not correlated with the severity of hyperlipidemia.


πŸ“œ SIMILAR VOLUMES


Is ect safe in patients with cerebrovasc
✍ Patricia Anna Blackburn; Peter Decalmer πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 435 KB πŸ‘ 2 views

## Abstract A 70‐year‐old man with a history of peripheral vascular disease was treated initially with antidepressants, then bilateral electroconvulsive therapy (ECT) for a depressive illness. Apart from an episode of delirium following ECT he recovered fully. Four years later he relapsed. Low‐dose

Coronary artery disease in patients with
✍ Roxann Rokey; Dr Loren A. Rolak; Yadollah Harati; N. Kutka; Mario S. Verani πŸ“‚ Article πŸ“… 1984 πŸ› John Wiley and Sons 🌐 English βš– 410 KB πŸ‘ 2 views

## Abstract Coronary artery disease is the cause of death in most patients who have transient ischemic attacks or stroke. Evaluation for this condition is not routinely performed in such patients, and no prospective studies have been reported. We prospectively examined 50 consecutive patients with

Cerebral blood flow and CO2 responsivene
✍ R. Bullock; A. D. Mendelow; I. Bone; J. Patterson; W. N. Macleod; G. Allardice πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 456 KB πŸ‘ 2 views

Abstract Resting cerebral blood flow (CBF) and the response to inhalation of 7 per cent CO2 was measured in 74 patients with symptoms of cerebrovascular disease. In order to evaluate their role in the identification of patients with significant arterial lesions, these measurements were correlated wi

Leukocyte alkaline phosphatase score in
✍ Natalio Walach; Amiram Guterman; Haim Rabinowitz; Suzana Kaufman; Beni Habot πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 217 KB

Leukocyte alkaline phosphatase (LAP) activity in peripheral blood was determined in 54 patients with cerebrovascular disease (CVD), 11 patients with primary brain tumor, and 23 patients with metastatic brain tumor. The LAP score of the primary brain tumor patients (155 -+ 40) was significantly highe